Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hemophagocytic syndrome caused by primary herpes simplex virus 1 infection: report of a first case.

Infection·2010

Same author

In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.

Antiviral research·2005

Same author

Fatal late-onset EBV-associated post transplant lymphoproliferative disease after umbilical cord blood transplantation due to persistent mixed chimerism and severe delay in T-cell recovery in a patient with Omenn's syndrome.

Bone marrow transplantation·2004

Same author

Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.

Archives of virology·2004

Same author

Establishment and cidofovir sensitivity of a cell line from a heart transplant recipient with multiple cutaneous tumors.

Neoplasma·2003

Same author

Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.

Virology·2003

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4⁺ T Cell in Acute LCMV-Infected Mice

Published on: April 26, 2024

Methods in Anti-HCMV Research.

J Neyts¹, G Andrei, R Snoeck

¹Rega Institute for Medical Research, Leuven, Belgium.

Methods in Molecular Medicine

|February 23, 2011

Summary

This summary is machine-generated.

Discovering potent and selective inhibitors for human cytomegalovirus (HCMV) infection is key. Assays require low virus input to accurately measure compound efficacy against viral replication.

More Related Videos

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8⁺ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice

Accessing Early Differentiation of Virus-Specific Follicular Helper CD4⁺ T Cell in Acute LCMV-Infected Mice

Published on: April 26, 2024

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

Published on: July 9, 2014

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8⁺ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Area of Science:

Virology
Drug Discovery
Antiviral Research

Background:

Human cytomegalovirus (HCMV) infection necessitates effective treatment strategies.
Identifying potent and selective inhibitors of HCMV replication is crucial for developing new therapies.
Compound selectivity requires a wide therapeutic window between antiviral and host cell toxicity.

Purpose of the Study:

To outline essential considerations for developing assays to screen for HCMV antiviral compounds.
To emphasize the importance of compound selectivity in antiviral drug discovery.
To detail methods for scoring antiviral activity against HCMV.

Main Methods:

Utilizing human fibroblast cultures to observe HCMV-induced cytopathic effects (CPE).
Employing microscopy for scoring potential antiviral activity.
Controlling viral input (multiplicity of infection, MOI) to ensure accurate assessment of compound efficacy.
Validating assays using reference antiviral compounds like ganciclovir, cidofovir, or foscarnet.

Main Results:

Low viral input (MOI) is critical to prevent early CPE masking compound effects.
High MOI leads to rapid CPE, obscuring the assessment of novel antiviral agents.
Microscopic scoring of CPE (e.g., on a 1-5 scale) is a practical method for screening.

Conclusions:

Accurate screening for HCMV inhibitors depends on optimizing assay conditions, particularly viral MOI.
Validated assays are essential for identifying selective compounds that effectively inhibit HCMV replication.
Standardized screening protocols facilitate the discovery of novel anti-HCMV therapeutics.